logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
V

Vadim S. Koshkin

university of california
H指数:29
被引数:5,226

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association between smoking, tumor genetics, and outcomes in men with metastatic prostate cancer

吸烟、肿瘤遗传学与转移性前列腺癌患者预后的关联

Prostate Cancer and Prostatic Diseases
IF5.8
2026-09-050
PRE
Christopher Choi; Matthew Labriola; Nicholas Henderson; Alec Chu; Clara Hwang; Pedro C. Barata; Frank Cameron Cackowski; Amanda Broderick; Rana R. McKay; Mehmet Asim Bilen; Deepak Kilari; Laura S. Graham; Abhishek Tripathi; Rohan Garje; Vadim S. Koshkin; Tanya B. Dorff; Michael Thomas Schweizer; Zachery R. Reichert; Alexandra O. Sokolova; Catherine H. Marshall; Andrew J. Armstrong
TROPION-Urothelial03: a phase II/III study of datopotamab deruxtecan (Dato-DXd) for locally advanced or metastatic urothelial carcinoma

TROPION-Urothelial03：达波替安德鲁克坦（Dato-DXd）治疗局部晚期或转移性尿路上皮癌的II/III期研究

Future Oncology
IF2.6
2026-05-160
PRE
Matthew D. Galsky; Alexandra Drakaki; Arnab Basu; Bradley McGregor; Jens Bedke; Yohann Loriot; Eiji Kikuchi; Jun Guo; Benjamin Garmezy; Srikala S. Sridhar; Parminder Singh; Vadim S. Koshkin; Mark Fleming; Gunnar Klauss; Daisy Lin; Chelsea Liu; Andrea B. Apolo; Thomas Powles
EXAMINING THE IMPACT OF TGF-B ACTIVITY ON FIBROBLAST INFILTRATION AND IMMUNE EXCLUSION IN MUSCLE-INVASIVE BLADDER CANCER

探讨TGF-B活性对肌肉浸润性膀胱癌中成纤维细胞浸润和免疫排斥的影响

Journal of Urology
IF6.8
2026-05-010
PRE
Gupta, Shilpa; De Jong, Joep J.; Alshalalfa, Mohammed; Chou, Jonathan; Koshkin, Vadim; Friedlander, Terence W.; Oh, David; Chu, Carissa E.; Mar, Nataliya; Sasse, Alexander; Wong, Anthony; Proudfoot, James A.; Davicioni, Elai; Seyedin, Steven Neema
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers

高级泌尿肿瘤共识会议（AUC3）2025：肾细胞癌和尿路肿瘤管理的专家共识

CA: A Cancer Journal for Clinicians
IF0
2025-12-130
OAAI
Rana R. McKay MD; Sumanta Pal MD; Wanling Xie MS; David Aggen MD, PhD; Laurence Albiges MD, PhD; Andrea Apolo MD; Michael B. Atkins MD; Rick Bangs MBA, PMP; Kathryn E. Beckermann MD, PhD; Joaquim Bellmunt MD, PhD; Stephanie A. Berg DO; Mehmet A. Bilen MD; David Braun MD, PhD; Maria I. Carlo MD; Jason Efstathiou MD, DPhil; Matthew Galsky MD; Petros Grivas MD, PhD; Shilpa Gupta MD; Naomi Haas MD; A. Ari Hakimi MD; Hans Hammers MD, PhD; Daniel Y. C. Heng MSC; Michelle Hirsch MD, PhD; Gopakumar Iyer MD; Eric Jonasch MD; Vadim S. Koshkin MD; Oleksandr Kryvenko MD; Bryan Lewis JD; Roger Li MD; Surena Matin MD; Benjamin Maughan MD, PharmD; David F. McDermott MD; Bradley McGregor MD; Joshua Meeks MD, PhD; Matthew Milowsky MD; Robert Motzer MD; Andrea Necchi MD; Dan Petrylak MD; Sima Porten MD, MPH; Thomas Powles MBBS, MRCP, MD; Brian Rini MD; Brian Shuch MD; Arlene Siefker-Radtke MD; Guru Sonpavde MD; S. Srikala Sridhar MD; Cristina Suarez MD, PhD; Chad Tang MD; Abhishek Tripathi MD; Michiel S. Van Der Heijden MD, PhD; Martin Voss MD; Wenxin Xu MD; Tian Zhang MD; Jonathan Rosenberg MD; Toni K. Choueiri MD
Efficacy of sacituzumab govitecan after enfortumab vedotin in advanced urothelial carcinoma: Analysis of the UNITE study

在恩沃利单抗之后的尿路上皮癌患者中，萨cituzumab govitecan的疗效：UNITE研究的分析

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
IF2.3
2025-12-010
OAAI
Jindal, Tanya; Jiang, Cindy Y.; Alhalabi, Omar; Davidsohn, Matthew; Freeman, Dory; Epstein, Ilana Y.; Bakaloudi, Dimitra Rafailia; Talukder, Rafee; Nizam, Amanda; Nguyen, Charles B.; Oh, Eugene; Tsung, Irene; Glover, Michael J.; Khaki, Ali Raza; Taylor, Amy K.; Jaime-Casas, Salvador; Jang, Albert; Lemke, Emily; Pywell, Cameron; Evans, Sean T.; Shin, Denny; Bilen, Mehmet A.; Basu, Arnab; Kilari, Deepak; Tripathi, Abhishek; Brown, Jason; Emamekhoo, Hamid; Davis, Nancy B.; Shah, Sumit; Gupta, Shilpa; Grivas, Petros; Bellmunt, Joaquim; Alva, Ajjai; Campbell, Matthew T.; Koshkin, Vadim S.
Genomic alterations and associated outcomes in patients with PSMA-positive metastatic castration-resistant prostate cancer treated with 177Lu-PSMA-617

PSMA阳性转移性去势抵抗性前列腺癌患者接受177Lu-PSMA-617治疗后的基因组改变及关联结局

ONCOLOGIST
IF4.2
2025-11-010
PRE
Panian, Justine; Henderson, Nicholas C.; Herchenhorn, Daniel; Barata, Pedro C.; Bilen, Mehmet Asim; Graham, Laura; Heath, Elisabeth; Hwang, Clara; Supernois, Avery; Kilari, Deepak; Thapa, Bicky; Koshkin, Vadim S.; Jindal, Tanya; Nauseef, Jones T.; Sokolova, Alexandra; Amery, Taylor; Zakharia, Yousef; Schweizer, Michael T.; Raychaudhuri, Ruben; Reichert, Zachery R.; Dorff, Tanya; Armstrong, Andrew J.; Wang, John; Alva, Ajjai; Mckay, Rana R.
Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study

FGFR3突变型晚期尿路上皮癌中，erdafitinib在enfortumab vedotin治疗前或治疗后的疗效：UNITE协作研究的分析

ONCOLOGIST
IF4.2
2025-11-010
PRE
Jiang, Cindy Y.; Hwang, Hyunsoo; Epstein, Ilana Y.; Bakaloudi, Dimitra Rafailia; Talukder, Rafee; Taylor, Amy K.; Nizam, Amanda; Jindal, Tanya; Glover, Michael J.; Khaki, Ali Raza; Barata, Pedro C.; Nguyen, Charles B.; Oh, Eugene; Davis, Nancy B.; Mabey, Hannah; Hoimes, Christopher J.; Evans, Sean T.; Abuqayas, Bashar; Lemke, Emily; Tsung, Irene; Qiao, Wei; Kilari, Deepak; Zakharia, Yousef; Bilen, Mehmet A.; Milowsky, Matthew, I; Shah, Sumit A.; Gupta, Shilpa; Emamekhoo, Hamid; Bellmunt, Joaquim; Alva, Ajjai S.; Grivas, Petros; Msaouel, Pavlos; Koshkin, Vadim S.; Campbell, Matthew T.; Alhalabi, Omar
Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study

接受恩沃利单抗维多汀治疗的晚期尿路上皮癌患者中的治疗相关不良事件及关联结局：UNITE研究的分析

CANCER MEDICINE
IF3.1
2025-10-020
OAAI
Nizam, Amanda; Nguyen, Charles B.; Li, Jinju; Zabor, Emily C.; Msaouel, Pavlos; Jiang, Cindy Y.; Alhalabi, Omar; Oh, Eugene; Davidsohn, Matthew P.; Epstein, Ilana B.; Bakaloudi, Dimitra Rafailia; Talukder, Rafee; Jindal, Tanya; Taylor, Amy K.; Glover, Michael J.; Khaki, Ali Raza; Lemke, Emily; Mabey, Hannah; Abuqayas, Bashar; Jang, Albert; Brown, Jason R.; Evans, Sean T.; Pywell, Cameron; Basu, Arnab; Bilen, Mehmet A.; Barata, Pedro C.; Zakharia, Yousef; Milowsky, Matthew I.; Kilari, Deepak; Hoimes, Christopher J.; Shah, Sumit A.; Emamekhoo, Hamid; Davis, Nancy B.; Gupta, Shilpa; Grivas, Petros; Bellmunt, Joaquim; Campbell, Matthew T.; Alva, Ajjai S.; Koshkin, Vadim S.
Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study

恩福妥单抗（Enfortumab Vedotin）在具有不同组织学亚型的晚期尿路上皮癌患者中的疗效：UNITE研究的分析

European Urology
IF25.2
2025-09-140
PRE
Tanya Jindal; Cindy Y. Jiang; Omar Alhalabi; Charles B. Nguyen; Eugene Oh; Irene Tsung; Dimitra Rafailia Bakaloudi; Rafee Talukder; Matthew Davidsohn; Dory Freeman; Ilana Y. Epstein; Chien-Kuang Cornelia Ding; Amanda Nizam; Michael J. Glover; Ali Raza Khaki; Amy K. Taylor; Emily Lemke; Albert Jang; Sean T. Evans; Denny Shin; Cameron Pywell; Arnab Basu; Mehmet A. Bilen; Yousef Zakharia; Pedro Barata; Matthew I. Milowsky; Jason Brown; Deepak Kilari; Hamid Emamekhoo; Christopher J. Hoimes; Sumit Shah; Nancy B. Davis; Shilpa Gupta; Petros Grivas; Joaquim Bellmunt; Ajjai Alva; Matthew T. Campbell; Vadim S. Koshkin
Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer

通过调节PPARγ通路上调NECTIN4，并增强膀胱癌中嵌合抗原受体（CAR）T细胞疗法。Nat. Commun. 16 (1), 8215

Nature Communications
IF15.7
2025-09-100
OAAI
Kevin Chang; Henry M. Delavan; Elizabeth Yip; Corynn Kasap; Jun Zhu; Roshan Lodha; Sheng-You Liao; Sarah C. Berman; Alberto Carretero-Gonzalez; Merve Basar; Gamze Gokturk Ozcan; Min Yuen Teo; David B. Solit; Jonathan E. Rosenberg; Hikmat Al-Ahmadie; Cornelia C. K. Ding; Emily Chan; Veronica Steri; Sima P. Porten; Vadim S. Koshkin; Terence W. Friedlander; Felix Y. Feng; John K. Lee; Arun P. Wiita; Carissa E. Chu; Jonathan Chou
Advanced urothelial carcinoma treated with enfortumab vedotin and pembrolizumab: a path to cure?

接受恩诺单抗 vedotin 和帕博利珠单抗治疗的晚期尿路上皮癌：治愈之路？

ONCOLOGIST
IF4.2
2025-09-011
OAAI
Jang, Albert; Tripathi, Nikita; Lanka, Sree M.; Kumar, Hamsa L. S.; Jain, Prateek; Calaway, Adam; Shoag, Jonathan E.; Vince, Randy; Mendiratta, Prateek; Rao, Santosh; Garcia, Jorge A.; Brown, Jason R.; Koshkin, Vadim S.; Campbell, Matthew T.; Singh, Parminder; Barata, Pedro C.
Urine Tumor DNA to Stratify the Risk of Recurrence in Patients Treated with Atezolizumab for Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer

尿液中肿瘤DNA用于分层评估接受阿替利珠单抗治疗的卡介苗难治性非肌层浸润性膀胱癌患者的复发风险

European Urology
IF25.2
2025-05-220
OAAI
Marie-Pier St-Laurent; Parminder Singh; David J. McConkey; M. Scott Lucia; Vadim S. Koshkin; Kelly L. Stratton; Trinity J. Bivalacqua; Wassim Kassouf; Sima P. Porten; Rick Bangs; Melissa Plets; Ian M. Thompson; Joshua J. Meeks; Vincent M. Caruso; Ceressa T. Ward; Brian C. Mazzarella; Kevin G. Phillips; Vincent T. Bicocca; Trevor G. Levin; Seth P. Lerner; Peter C. Black
Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study Data

与恩夫妥单抗韦汀疗效相关的基因组生物标志物：对UNITE研究数据的分析

EUROPEAN UROLOGY ONCOLOGY
IF9.3
2024-12-011
OAAI
Jindal, Tanya; Jiang, Cindy; Alhalabi, Omar; Nizam, Amanda; Nguyen, Charles; Talukder, Rafee; Bakaloudi, Dimitra; Davidsohn, Matthew; Freeman, Dory; Glover, Michael; Khaki, Ali Raza; Evans, Sean; Lemke, Emily; Bose, Rohit; Sim, Woogwang; Pywell, Cameron; Basu, Arnab; Kilari, Deepak; Barata, Pedro C.; Bilen, Mehmet A.; Zakharia, Yousef; Milowsky, Matthew I.; Shah, Sumit A.; Bellmunt, Joaquim; Grivas, Petros; Emamekhoo, Hamid; Davis, Nancy B.; Gupta, Shilpa; Hoimes, Christopher; Campbell, Matthew T.; Alva, Ajjai; Koshkin, Vadim S.
Efficacy of enfortumab vedotin (EV) in patients (pts) with (w) advanced urothelial carcinoma (aUC) who have baseline neuropathy (N) and/or diabetes mellitus (DM): A UNITE study analysis

恩诺妥昔单抗（EV）在具有基线神经病变（N）和/或糖尿病（DM）的晚期尿路上皮癌（aUC）患者（pts）中的疗效：一项UNITE研究的分析

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Jang, A.; Jindal, T.; Jiang, C. Y.; Nguyen, C. B.; Nizam, A.; Alva, A. S.; Grivas, P.; Bellmunt, J.; Hoimes, C. J.; Bilen, M. A.; Emamekhoo, H.; Milowsky, M. I.; Khaki, A. R.; Gupta, S.; Campbell, M. T.; Alhalabi, O.; Chen, Z.; Fu, P.; Koshkin, V. S.; Brown, J. R.
PrECOG PrE0807: A Phase 1b Feasibility Trial of Neoadjuvant Nivolumab Without and with Lirilumab in Patients with Muscle-invasive Bladder Cancer Ineligible for or Refusing Cisplatin-based Neoadjuvant Chemotherapy
EUROPEAN UROLOGY ONCOLOGY
IF9.3
2024-08-015
PRE
Grivas, Petros; Koshkin, Vadim S.; Chu, Xiangying; Cole, Suzanne; Jain, Rohit K.; Dreicer, Robert; Cetnar, Jeremy P.; Sundi, Debasish; Gartrell, Benjamin A.; Galsky, Matthew D.; Woo, Brianna; Li-Ning-Tapia, Elsa; Hahn, Noah M.; Carducci, Michael A.

研究方向

暂未获取到该数据
P
Petros Grivas
H 指数:61论文数:916被引数:2.4万
P
Pedro C. Barata
H 指数:33论文数:596被引数:4,624
M
Mehmet Asım Bilen
H 指数:49论文数:665被引数:1.1万
A
Ajjai Alva
H 指数:59论文数:458被引数:1.6万
R
Rana R. McKay
H 指数:57论文数:1,239被引数:1.5万
D
Deepak Kilari
H 指数:21论文数:212被引数:1,767
T
Tanya Jindal
H 指数:9论文数:64被引数:349
M
Matthew I. Milowsky
H 指数:66论文数:575被引数:1.8万
M
Matthew D. Galsky
H 指数:79论文数:852被引数:3.4万
J
Joaquim Bellmunt
H 指数:106论文数:1,140被引数:6.6万